ÂÜÀòÂÒÂ×

The Leadership Team at Concarlo Holdings oversees the strategic direction and operational management of the company, driving innovation in precision medicine for oncology. Comprising seasoned experts, including the Chief Development Officer and co-founders, they collaborate to align research initiatives with clinical objectives, ensuring the successful development and commercialization of therapies targeting the p27Kip1 pathway.